Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Anti-inflammatory Signalling Downregulates inflammatory cytokines at injury sites, supporting faster resolution of acute inflammation during the repair cascade
PL-14736 Amino-acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular formula (free base): C 62 H 98 N 16 O 22 Molecular weight (free base): ~1,419.5 g/mol CAS: 137525-51-0 Form: Lyophilised powder Appearance: White to off-white solid Handling & storage Storage (dry): Keep vials protected from light and moisture
Bull.,2006, 29, 1554-1558 17
Consistent with this concept, up to 30% of individuals with PsO eventually develop PsA, a chronic inflammatory arthropathy affecting peripheral joints, entheses, and the axial skeleton ( Early PsA may display nonspecific musculoskeletal symptoms, such as inflammatory arthralgia or morning stiffness, even in the absence of overt synovitis or radiographic erosions ( At the pathogenic level, PsO and PsA share core inflammatory mechanisms driven by dysregulation of the IL17/IL23 and Tumour Necrosis Factor (TNF)- cytokine axes ( These immune pathways are closely intertwined with metabolic abnormalities, particularly obesity and adipose tissue dysfunction
20C discharge = 40A, lasting only 3 minutes
